Artes Medical Announces Completion Of Enrollment In 1,000 Patient Post-Marketing ArteFill Study (Dermal Filler)
Artes Medical, Inc. (Nasdaq:ARTE), a medical aesthetics company, today announced that enrollment has been completed in the 1,000-patient post-marketing study required by the FDA. The study follows patients treated with ArteFill®, the first and only FDA-approved non-resorbable dermal filler, for a five-year period. medicalnewstoday.com |
FDA Gives Update On Botulinum Toxin Safety Warnings; Established Names Of Drugs Changed
The U.S. Food and Drug Administration announced an update to a previous safety alert on four botulinum toxin drug products, noting that all of them now have boxed warnings on their labels and have developed Medication Guides for patients, as directed by the agency in April 2009. The boxed warning cautions that the effects of the botulinum toxin may spread from the area of injection to other areas of the body, causing symptoms similar to those of botulism. medicalnewstoday.com |
News From Plastic Surgery 2009
Botox Takes a Shot at Pain No longer just a wrinkle fighter, Botox® may have indications as a pain medication to fight Chronic Regional Pain Syndrome (CRPS), reports a new study presented at the American Society of Plastic Surgeons (ASPS) Plastic Surgery 2009 conference, Oct. 23-27, in Seattle. Between 5 and 26 people out of every 100,000 have their lives significantly disrupted by some form of chronic pain. medicalnewstoday.com |
Joint Replacement, Does This Look Infected To You?
The American Academy of Orthopaedic Surgeons (AAOS) recently approved and released an evidence-based clinical practice guideline on the diagnosis of periprosthetic joint infections of the hip and knee. Clinical practice guidelines are one avenue the Academy uses to ensure that patients receive high quality care... mnt.to |
Normal Blood Glucose Levels In Diabetics Presenting For Surgery Were Associated With Increased Risk Of Mortality From Non-Cardiac Surgery
A clinical study presented at ANESTHESIOLOGY 2010 discovered that diabetics who presented for non-cardiac surgery with near normal blood sugar levels were at increased risk of death, as compared with their non-diabetic counterparts... mnt.to |